Syntax Bio expands Series A to $14.4M, inks Mayo Clinic collaboration

A local stem cell therapy company added several new investors as part of its Series A expansion. Learn more here.

Syntax Bio and Applied StemCell Announce Strategic Collaboration to Advance Stem Cell Innovation

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Applied StemCell Corp. (ASC), ...
Business Wire

WEBs and Syntax Data Partner to Launch New Defined Volatility Indexes

PARK CITY, Utah--(BUSINESS WIRE)--WEBs, an innovator in volatility-managed investment strategies, and Syntax Data, a financial data and technology company that codifies business models into a ...

Syntax Bio expands Series A to $14.4M, adds leadership and board members

Syntax Bio expands Series A to $14.4M to boost CRISPR Cellgorithm platform and type 1 diabetes beta-cell therapy amid tough biotech funding—read more.
Los Angeles Times

English Syntax Explained

If there’s one thing you can be sure of, it’s that English Syntax can definitely get interesting. Syntax is the branch of linguistics that deals with sentences and their structures. In case you’re ...
Business Wire

Syntax Bio Announces Collaboration with Mayo Clinic to Advance Pancreatic Cell Therapy for Type 1 Diabetes

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on ...